Natalizumab: Parvovirus B19 infection and acute acalculous cholecystitis: case report.

MLA

“Natalizumab: Parvovirus B19 Infection and Acute Acalculous Cholecystitis: Case Report.” Reactions Weekly, vol. 1859, no. 1, June 2021, p. 279. EBSCOhost, https://doi.org/10.1007/s40278-021-97375-4.

APA

Natalizumab: Parvovirus B19 infection and acute acalculous cholecystitis: case report. (2021). Reactions Weekly, 1859(1), 279. https://doi.org/10.1007/s40278-021-97375-4

Chicago

“Natalizumab: Parvovirus B19 Infection and Acute Acalculous Cholecystitis: Case Report.” 2021. Reactions Weekly 1859 (1): 279. doi:10.1007/s40278-021-97375-4.